GE HealthCare backs FY24 adjusted EPS view $4.20-$4.35, consensus $4.27

Sees FY24: Organic revenue growth in the range of 1% to 2% year-over-year versus the prior guide of approximately 4%, due to China market headwinds. Adjusted EBIT margin in the range of 15.7% to 16.0%, reflecting an expansion of 60 to 90 basis points versus 2023. Adjusted EBIT margin of 15.1%; this compares to prior guidance of 15.6% to 15.9%. Adjusted effective tax rate in the range of 23% to 25%. Adjusted EPS in the range of $4.20 to $4.35, representing 7% to 11% growth versus Adjusted EPS of $3.93 for 2023. Free cash flow of approximately $1.8 billion.